Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changyan Chen

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Elife|November 3, 2020
Protein phase separation and its role in tumorigenesisShan Jiang, Johan Bourghardt Fagman, Changyan Chen, et al.
Genes & Cancer|March 23, 2019
Chronic low dose arsenic exposure preferentially perturbs mitotic phase of the cell cycleSuthakar Ganapathy, Jian Liu, Rui Xiong, et al.
Cell Cycle (Georgetown, Tex.)|December 9, 2014
Induction of mitotic catastrophe by PKC inhibition in Nf1-deficient cellsXiaodong Zhou, Sung-Hoon Kim, Ling Shen, et al.
Carcinogenesis|November 4, 2020
Transcription factor Sp1 is upregulated by PKCι to drive the expression of YAP1 during pancreatic carcinogenesisJinhe Yang, Junli Wang, Hongmei Zhang, et al.
Scientific Reports|June 22, 2026
Comprehensive behavioral and demographic correlates in myopia risk among Tibetan adolescents: a machine learning analysis using non‑cycloplegic refractionJin Han, JuanYang Yang, Yuzhen Suolang, et al.
Aging|February 25, 2022
PKC is an indispensable factor in promoting environmental toxin chromium-mediated transformation and drug resistanceSuthakar Ganapathy, Jian Liu, Tianqi Yu, et al.
Toxicology and Applied Pharmacology|November 17, 2016
Corrigendum to "Low doses of arsenic, via perturbing p53, promotes tumorigenesis" [Toxicol. Appl. Pharmacol. (2016) 98-104]Suthakar Ganapathy, Ping Li, Johan Fagman, et al.
Molecular Carcinogenesis|February 21, 2017
Chromium IV exposure, via Src/Ras signaling, promotes cell transformationSuthakar Ganapathy, Ping Li, Jean Lafontant, et al.
Toxicology and Applied Pharmacology|July 19, 2016
Low doses of arsenic, via perturbing p53, promotes tumorigenesisSuthakar Ganapathy, Ping Li, Johan Fagman, et al.
Oncotarget|October 11, 2014
Regulation of the viability of Nf1 deficient cells by PKC isoformsXiaodong Zhou, Ling Shen, Toshima Parris, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Elife|November 3, 2020
Protein phase separation and its role in tumorigenesisShan Jiang, Johan Bourghardt Fagman, Changyan Chen, et al.
Genes & Cancer|March 23, 2019
Chronic low dose arsenic exposure preferentially perturbs mitotic phase of the cell cycleSuthakar Ganapathy, Jian Liu, Rui Xiong, et al.
Cell Cycle (Georgetown, Tex.)|December 9, 2014
Induction of mitotic catastrophe by PKC inhibition in Nf1-deficient cellsXiaodong Zhou, Sung-Hoon Kim, Ling Shen, et al.
Carcinogenesis|November 4, 2020
Transcription factor Sp1 is upregulated by PKCι to drive the expression of YAP1 during pancreatic carcinogenesisJinhe Yang, Junli Wang, Hongmei Zhang, et al.
Scientific Reports|June 22, 2026
Comprehensive behavioral and demographic correlates in myopia risk among Tibetan adolescents: a machine learning analysis using non‑cycloplegic refractionJin Han, JuanYang Yang, Yuzhen Suolang, et al.
Aging|February 25, 2022
PKC is an indispensable factor in promoting environmental toxin chromium-mediated transformation and drug resistanceSuthakar Ganapathy, Jian Liu, Tianqi Yu, et al.
Toxicology and Applied Pharmacology|November 17, 2016
Corrigendum to "Low doses of arsenic, via perturbing p53, promotes tumorigenesis" [Toxicol. Appl. Pharmacol. (2016) 98-104]Suthakar Ganapathy, Ping Li, Johan Fagman, et al.
Molecular Carcinogenesis|February 21, 2017
Chromium IV exposure, via Src/Ras signaling, promotes cell transformationSuthakar Ganapathy, Ping Li, Jean Lafontant, et al.
Toxicology and Applied Pharmacology|July 19, 2016
Low doses of arsenic, via perturbing p53, promotes tumorigenesisSuthakar Ganapathy, Ping Li, Johan Fagman, et al.
Oncotarget|October 11, 2014
Regulation of the viability of Nf1 deficient cells by PKC isoformsXiaodong Zhou, Ling Shen, Toshima Parris, et al.
Pageof 5